Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
27 February 2025 | Story Edzani Nephalela | Photo Supplied
Teacher Training in Lesotho 2025
Various stakeholders participated in the two-day workshop from 16 to 17 January 2025 as part of the Online Teacher Training in Mathematics and Science on Content project. The initiative aims to equip secondary school mathematics and science teachers across Lesotho with essential skills.

The Faculty of Education at the University of the Free State (UFS) has taken a significant step in regional engagement and educational transformation through its partnership with Lesotho’s Ministry of Education and Training. In October 2023, the faculty, through its Mathematics, Natural Sciences, and Technology Education Department, embarked on an R11 million project to provide online training for 235 mathematics and science teachers in secondary schools across Lesotho.

The Online Teacher Training in Mathematics and Science Content project will mark its final stage on 28 February 2025, following a two-day workshop from 16 to 17 January 2025. The workshop brought together key stakeholders to reflect on its impact and explore opportunities for further collaboration in teacher development. This project aligns with the UFS’s Vision 130 strategy, reinforcing its commitment to research-led, student-centred, and socially responsive education.

 “This initiative is an example of our dedication to leveraging digital learning tools to address regional education challenges,” said Dr Kwazi Magwenzi, Director of Projects and Innovation at the UFS Faculty of Education. “By equipping teachers with enhanced pedagogical skills, we are contributing to long-term improvements in the quality of education in Lesotho.”

Strengthening regional collaboration and societal development

Over the past few years, the faculty has also strengthened its role in delivering high-quality education programmes, such as the Southern African region’s SANRAL Mathematics and Science PhD Programme. Through close collaboration with industry partners, public institutions, and the private sector, the faculty has extended its reach to the Southern African Development Community (SADC), ensuring its teacher development programmes remain relevant and impactful.

“One of our key objectives is to address pressing societal needs actively,” Dr Magwenzi added. “Our commitment to regional engagement means leveraging our expertise to contribute meaningfully to the development of the African continent, particularly in Southern Africa. As our close neighbour, Lesotho was a natural focus for this initiative.”

Expanding the faculty’s footprint in the region

The success of this initiative has laid the foundation for expanding the UFS’s regional footprint through additional short courses tailored to societal needs. The faculty envisions extending its expertise to other regions, further solidifying its position as a leader in education and research.

“As we conclude this phase of the project, we are inspired to build on these achievements,” said Prof Maria Tsakeni, Associate Professor and Head of the Department of Mathematics, Natural Sciences, and Technology Education in the Faculty of Education. “This initiative has demonstrated the power of strategic partnerships and innovative learning models. Moving forward, we aim to design more programmes that contribute to the educational and economic growth of the region.”

By fostering regional collaboration, enhancing teacher competencies, and driving educational innovation, the Faculty of Education at the UFS continues to shape the future of education in Africa. This initiative is a testament to its unwavering commitment to academic excellence and societal transformation.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept